# Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/gemcitabine-and-oxaliplatin-in-advanced-transitional-cell-carcinoma-of-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stéphane Culine,Xavier Rébillard,F. Iborra,Nicolas Mottet,A. Faix,Didier Ayuso,Frédéric Pinguet |
| Citations | 29 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2307586356 |
| PMID | 12820476 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Nicolas Mottet](https://scholariq.org/researchers/nicolas-mottet/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Paper topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.